Home
ABVC

ABVC

ABVC BioPharma Inc.

as of 12-15-2025 2:05pm EST

$2.11

$0.00

0.00%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Chart Type:

Time Range:

Founded:	2015	Country:	United States
Employees:	N/A	City:	FREMONT
Market Cap:	58.6M	IPO Year:	N/A
Target Price:	N/A	AVG Volume (30 days):	68.8K
Analyst Decision:	N/A	Number of Analysts:	N/A
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.29	EPS Growth:	N/A
52 Week Low/High:	$0.40 - $5.48	Next Earning Date:	11-03-2025
Revenue:	$797,916	Revenue Growth:	56.52%
Revenue Growth (this year):	735.18%	Revenue Growth (next year):	N/A

AI-Powered ABVC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold

Model Accuracy: 69.33%

69.33%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full ABVC Forecast & Prediction with Hourly Data

Compare ABVC vs Leading Stocks

See how ABVC stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free ABVC Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "ABVC ABVC BioPharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.